Suchergebnisse - "Gadelha, Mônica"

PubPharm (24)

1

Pituitary acting drugs : cabergoline and pasireotide

enthalten in: Pituitary | 2022

von Gadelha, M. | Wildemberg, L. | Shimon, I.

2

enthalten in: Presse medicale (Paris, France : 1983) | 2021

von Wildemberg, L. | Fialho, C. | Gadelha, M.

3

Brazilian multicenter study on pegvisomant treatment in acromegaly

enthalten in: Archives of endocrinology and metabolism | 2019

von Boguszewski, C. | Huayllas, M. | Vilar, L. | +12

CommentIn: Arch Endocrinol Metab. 2019 Aug 22;63(4):318-319. - PMID 31460621

4

Treatment escape reduces the effectiveness of cabergoline during long-term treatment of acromegaly in monotherapy or in association with first-generation somatostatin receptor ligands

enthalten in: Clinical endocrinology | 2018

von Kasuki, L. | Dalmolin, M. | Wildemberg, L. | +1

5

Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism

enthalten in: Archives of endocrinology and metabolism | 2018

von Vilar, L. | Abucham, J. | Albuquerque, J. | +22

6

Dopamine receptor subtype 2 expression profile in nonfunctioning pituitary adenomas and in vivo response to cabergoline therapy

enthalten in: Clinical endocrinology | 2015

von Vieira Neto, L. | Wildemberg, L. | Moraes, A. | +7

7

Cabergoline treatment in acromegaly : cons

enthalten in: Endocrine | 2014

von Kasuki, L. | Vieira Neto, L. | Gadelha, M.

8

Acromegaly and pregnancy : a prospective study

enthalten in: European journal of endocrinology | 2014

von Dias, M. | Boguszewski, C. | Gadelha, M. | +4

9

Cabergoline treatment in acromegaly: cons

enthalten in: Endocrine | 2014

von Kasuki, L. | Vieira Neto, L. | Gadelha, M.

10

Cabergoline treatment in acromegaly: cons

enthalten in: Endocrine | 2014

von Kasuki, L. | Vieira Neto, L. | Gadelha, M.